Vitiligo is not a cosmetic disease

J Am Acad Dermatol. 2015 Nov;73(5):883-5. doi: 10.1016/j.jaad.2015.07.039.

¹ University of Bordeaux and National Reference Center for Rare Skin Diseases and Hôpital St-André, Bordeaux, France. Electronic address: khaled.ezzedine@aphp.fr.
² Brigham and Women's Hospital, Boston, Massachusetts.
³ Department of Dermatology, St Vincent's Hospital and Royal Children's Hospital, Skin and Cancer Foundation, Melbourne, Australia.
⁴ Center of Evidence-Based Dermatology, University of Nottingham, Nottingham, United Kingdom.
⁵ Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
⁶ Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
⁷ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.

No abstract available

Keywords: autoimmune disease; burden; cosmetic; insurance payers; patient-reported outcomes; quality of life; reimbursement; vitiligo.

MeSH terms